Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06366490
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-03-28
Brief Title:
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer
Sponsor:
PhotonPharma Inc
Organization:
PhotonPharma Inc
Organization Data
Organization:
PhotonPharma Inc
Class:
INDUSTRY
Study ID:
CIP2023-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PhotonPharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None